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Objective: Atrial fibrillation after cardiac surgery is a frequent complication. In this study we studied various
factors in addition to trying to identify a marker that would predict the potential for atrial fibrillation before sur-
gical intervention to prevent its occurrence.
Methods: We targeted 234 cases in which isolated coronary artery bypass grafting had been performed. The
items for study included age, EuroSCORE, and maximum values of creatine phosphokinase–MB, troponin I,
and angiotensin II after surgical intervention and preoperative values of atrial natriuretic peptide, brain natriuretic
peptide, and C-reactive protein. As fibrotic markers, we measured levels of the sialylated carbohydrate antigen
KL-6 in the blood, hyaluronic acid, and pyridinoline cross-linked carboxyterminal telepeptide of type I collagen
C. At the time of surgical intervention, a section of the right atriumwas extracted, and atrial natriuretic peptide, the
sialylated carbohydrate antigen KL-6, hyaluronic acid, and pyridinoline cross-linked telopeptide of type I colla-
gen levels were measured.
Results: Atrial fibrillation was observed in 73 (31.2%) cases, and preoperative factors that showed statistically
significant differences in the occurrence of atrial fibrillation included age, EuroSCORE, and preoperative values
of atrial natriuretic peptide, angiotensin II, the sialylated carbohydrate antigen KL-6, hyaluronic acid, and pyri-
dinoline cross-linked telopeptide of type I collagen in the blood. As for intraoperative and postoperative factors,
statistically significant differences were observed in the postoperative maximum of angiotensin II, atrial natri-
uretic peptide of the right atrium, the sialylated carbohydrate antigen KL-6, hyaluronic acid, and pyridinoline
cross-linked telopeptide of type I collagen levels.
Conclusion: The fibrosis of tissue associated with age is believed to be closely related to the occurrence of atrial
fibrillation after coronary artery bypass grafting. This study suggests that the preoperative values of atrial natri-
uretic peptide, angiotensin II, the sialylated carbohydrate antigen KL-6, hyaluronic acid, and pyridinoline cross-
linked telopeptide of type I collagen in the blood are useful as a new index for the occurrence of atrial fibrillation
after coronary artery bypass grafting.Atrial fibrillation (AF) after cardiac surgery is a frequent
complication, with a rate of occurrence that has been
reported to range from 18.3% to 33%.1-4 Various studies re-
garding the causes of its occurrence have been conducted,
including advanced age,1-7 sex,2 body mass index,4,5 left
atrial dimensions,5 low cardiac function,4,6 chronic respira-
tory failure,4,7 and renal dysfunction,6 but no definitive con-
sensus has yet been reached. However, one fact that is
common among the various reports in the past is that
advanced age is believed to be one of the factors. The occur-
rence of postoperative AF also has an effect on a patient’s
prognosis, resulting in an increased hospital stay, and there-
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doi:10.1016/j.jtcvs.2008.10.003The Journal of Thoracic andfore prevention of its occurrence is important. In the elderly,
in particular, it is important to predict and prevent postoper-
ative AF before surgical intervention because complications
occur in many cases as a result of a lengthy hospital stay,
which strongly affects the patient prognosis.
In this study related to the occurrence of postoperative
AF, we examined several factors. Many reports suggesting
that age has a strong effect on the occurrence of postopera-
tive AF have been presented in the past, and we measured
levels of the sialylated carbohydrate antigen KL-6, hyalur-
onic acid, pyridinoline cross-linked telopeptide of type I col-
lagen (I-CTP), and atrial natriuretic peptide (ANP) as
indicators of the fibrosis of tissue to prevent the occurrence
thereof.We thereafter examined whether any of these factors
could be used as markers for predicting the occurrence of
postoperative AF before surgical intervention.
MATERIALS AND METHODS
We targeted 234 consecutive cases in which isolated coronary artery by-
pass grafting (CABG) had been performed in our institute, but cases of acute
myocardial infarction and patients who had a history of arrhythmia were ex-
cluded from this study. CABG with cardiopulmonary bypass (CPB) wasCardiovascular Surgery c Volume 137, Number 4 895
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ACE-I ¼ angiotensin-converting enzyme inhibitor
AF ¼ atrial fibrillation
ANP ¼ atrial natriuretic peptide
ARB ¼ angiotensin II receptor blocker
BNP ¼ brain natriuretic peptide
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
CRP ¼ C-reactive protein
I-CTP ¼ pyridinoline cross-linked telopeptide
of type I collagen
OR ¼ odds ratio
RAAS ¼ renin–angiotensin–aldosterone system
conducted in all cases by using the intermittent aortic crossclamp method,
which does not use cardioplegia. The heart rate was monitored for a week
after surgical intervention, and we studied its relationship to the occurrence
of AF. In this study we defined AF as either cases that continued for more
than 5 minutes or cases in which treatment was required due to the hemody-
namic conditions. Regarding the treatment for AF, we administered 50 mg
of pilsicainide hydrochloride (Sunrythm; AsubioPharma, Daiichi Sankyo,
Tokyo, Japan) parenterally for 30 minutes, and then pilsicainide hydrochlo-
ride was administered internally as a first choice and amiodarone hydrochlo-
ride (Ancaron; Aventis Pharma, Tokyo, Japan) was administered internally
for cases in which no effect was achieved.
The items for study included age, sex, incidence of emergency surgical
intervention, body surface area, previous myocardial infarction, Euro-
SCORE, use of preoperative internal medicine (b-blockers, calcium antag-
onists, angiotensin II receptor blockers [ARBs], and angiotensin-converting
enzyme inhibitors [ACE-Is]), diabetes mellitus, hypertension, hyperlipemia,
history of smoking, use of hemodialysis, cerebrovascular disorders, cardiac
function (left ventricular ejection fraction), and left atrial dimensions. We
measured the ANP, brain natriuretic peptide (BNP), angiotensin II, and
C-reactive protein (CRP) levels in the blood before surgical intervention.
We also measured KL-6, hyaluronic acid, and I-CTP levels in the blood
as markers of fibrosis. At the time of surgical intervention, a section of
the right atrium was extracted, and we measured the levels of ANP
(radioimmunoassay method; Shionogi, Co, Ltd, Tokyo, Japan), KL-6
(enzyme-linked immunosorbent assay method; Sanko Junyaku, Tokyo,
Japan), hyaluronic acid (latex agglutination turbidimetric immunoassay;
Mitsubishi Kagaku Latron, Inc, Tokyo, Japan), and I-CTP (radioimmunoas-
say method; TFB, Inc, Tokyo, Japan) therein. Regarding intraoperative and
postoperative factors, aortic crossclamp time, CPB time, number of
bypasses, operative mortality, complications (including cerebral infarction,
respiratory failure, acute renal failure, acute cardiac failure, mediastinitis,
and gastrointestinal complications), length of hospital stay, and, in a bio-
chemical examination of the blood, creatinine phosphokinase–MB isoen-
zyme, troponin I, and CRP levels were measured immediately after
surgical intervention, 3 hours after surgical intervention, and on the first,
second, and third days after surgical intervention. ANP, BNP, and angioten-
sin II levels were measured immediately after surgical intervention and on
the first and third days after surgical intervention. The maximum and
minimum values of ANP were also measured and compared.
Results are expressed as the mean  standard deviation. By using para-
metric and nonparametric data, statistically significant differences were
determined by using the Student’s t test and the Fisher’s exact test, respec-
tively. We compared patients with postoperative AF and those without AF
regarding patient background, preoperative blood test findings, results896 The Journal of Thoracic and Cardiovascular Suduring and after surgical intervention, and postoperative blood test findings
by using the Fisher’s univariate exact test or the unpaired Student’s t test.
Independent predictors for postoperative AFwere examined by using a mul-
tivariate analysis with a logistic regression from the parameters detected by
means of univariate analysis. All analyses were conducted with SPSS soft-
ware (SPSS, Inc, Chicago, Ill).
RESULTS
After CABG, AF was observed in 73 (31.2%) cases, and
the time of occurrence averaged 2.42  1.03 days (0–5
days). The sinus rhythm in all cases improved as a result
of treatment. There were 2 cases of operative mortality,
and both were cases of emergency surgical intervention
for patients with unstable angina. These patients had perio-
perative myocardial infarction and died of cardiac failure.
Postoperative AF was observed in both cases. The cases of
postoperative complications were as follows: 2 cases of ce-
rebral infarction, 4 cases of acute cardiac failure, 3 cases of
mediastinitis, 2 cases of acute renal failure, 2 cases of respi-
ratory failure, 2 cases of gastrointestinal complication, and 1
case of hemorrhage. Postoperative AF was observed in 2
cases of cerebral infarction, 4 cases of acute cardiac failure,
2 cases of mediastinitis, 2 cases of acute renal failure, 1 case
of respiratory failure, 1 case of gastrointestinal complication,
and 1 case of hemorrhage (Table 1).
The preoperative factors that showed statistically signifi-
cant differences in the occurrence of AF included age, Euro-
SCORE, and preoperative values of ANP, angiotensin II,
KL-6, hyaluronic acid, and I-CTP in the blood (Table 2).
There were no differences in the risk factors, including
sex, body surface area, hypertension, preoperative internal
medicine treatment, previous incidence of myocardial in-
farction, incidence of emergency surgical intervention, pre-
operative ejection fraction, left atrial dimension, BNP, and
CRP (Table 2).
Regarding intraoperative and postoperative factors, there
were statistically significant differences observed in opera-
tive mortality, postoperative complications, length of hospi-
tal stay, maximum angiotensin II level after surgical
intervention, ANP level in the right atrium, and KL-6, hya-
luronic acid, and I-CTP levels. There were also no signifi-
cant differences in the maximum postoperative value of
TABLE 1. Postoperative complications
AF (þ) AF ()
Cerebral infarction 2 0
Acute cardiac failure 4 0
Mediastinitis 2 1
Acute renal failure 2 0
Respiratory failure 1 1
Gastrointestinal complication 1 1
Hemorrhage 1 0
Total 13 3
AF, Atrial fibrillation.rgery c April 2009
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which AF did not occur was significantly lower than the
number in which AF did occur at the minimum value. No
significant differences were observed regarding the aortic
crossclamp time, CPB time, postoperative peak of creatinine
phosphokinase–MB isoenzyme, and troponin I and CRP
values (Table 3). We were unable to obtain a measured value
of KL-6 in the right atrium, and therefore we believe that it
was not secreted from the right atrium.
The items that were categorized as risk factors for postop-
erative AF included a EuroSCORE of at least 8 points (odds
ratio [OR], 6.37; 95% confidence interval (CI), 1.16–34.98;
P ¼ .033) in the logistic regression analysis, age of at least
70 years (OR, 5.89; 95%CI, 2.05–16.97; P¼ .001), a preop-
erative value of no more than 20 pg/mL of ANP in the blood
(OR, 5.45; 95% CI, 1.0–30.02; P¼ .045), the occurrence of
postoperative complications (OR, 5.09; 95%CI, 1.25–20.69;
P ¼ .023), at least 30 U/mL of KL-6 (OR, 4.61; 95% CI,
1.29–18.69; P ¼ .04), at least 10 ng/mL I-CTP (OR, 2.99;
95% CI, 1.17–22.9; P ¼ .04), and at least 80 ng/mL of hya-
luronic acid (OR, 2.18; 95% CI, 1.15–13.33; P ¼ .03).
TABLE 2. Preoperative background of patients and preoperative data
AF (þ) (n ¼ 73) AF () (n ¼ 161) P value
Age (y) 72.1  7.07 66.05  9.54 <.001
Male sex 51 129 .084
BSA (m2) 1.63  0.16 1.64  0.15 .765
Diabetes mellitus 38 83 .609
Hypertension 60 122 .274
Hyperlipidemia 40 91 .805
Hyperuricemia 13 26 .752
Smoking 18 60 .058
Previous MI 28 49 .232
Emergency 26 47 .326
Hemodialysis 3 13 .266
CVD 8 13 .475
Ejection fraction (%) 59.7  11.9 60.4  12.8 .723
Left atrial
diameter (mm)
34.6  7.1 32.1  8.8 .095
BNP (pg/dL) 137.2  215.7 149.7  262.0 .751
EuroSCORE 6.15  3.01 4.36  3.49 .0002
KL-6 (U/mL) 281.0  147.3 229.8  111.1 .019
ANP (pg/dL) 38.8  32.2 51.4  49.8 .043
I-CTP (ng/mL) 10.47  6.89 6.17  7.36 .007
Hyaluronic acid (ng/mL) 80.9  60.2 44.9  43.8 <.001
CRP (mg/dL) 0.69  1.74 1.19  2.79 .230
Angiotensin II (pg/dL) 16.7  29.1 9.1  8.0 .0064
ARB use 26 51 .554
ACE-I use 13 60 .091
Ca antagonist use 23 48 .794
b-Blocker use 12 15 .114
AF, Atrial fibrillation; BSA, body surface area; MI, myocardial infarction; CVD, cere-
brovascular disease; BNP, brain natriuretic peptide; ANP, atrial natriuretic peptide; I-
CTP, hyaluronic acid, pyridinoline cross-linked telopeptide of type I collagen; CRP,
C-reactive protein; ARB, angiotensin II receptor blocker; ACE-I, angiotensin-convert-
ing enzyme inhibitor; Ca, calcium.The Journal of Thoracic andWhen the correlation of the values was analyzed among
the blood levels of ANP, hyaluronic acid, and I-CTP, for
the levels in the right atrium, ANP resulted in an r value
of 0.578 (P<.001) and hyaluronic acid resulted in an r value
of 0.553 (P< .001), thus indicating a good correlation. On
the other hand, I-CTP resulted in an r value of 0.091 (P ¼
.349), and no correlation was found (Figure 1).
DISCUSSION
Studies related to the occurrence of AF after cardiac sur-
gery have been conducted from various perspectives, and the
factors of its occurrence were incorporated into a large-scale
study conducted on more than 1000 cases, including
advanced age, preoperative low cardiac function, renal
dysfunction, cases of subsequent surgical intervention, use
of a preoperative b-blocker, hypertension, hyperlipidemia,
chronic cardiac failure, cerebrovascular disease, peripheral
vessel disorder, history of chronic obstructive pulmonary
disease, obesity, use of intra-aortic balloon pumping, use
of CPB, history of arrhythmia, cases of left main coronary
trunk, multivessel disease, use of ACE-I, digitalis, and
a large left atrium.3-7 However, no definitive consensus
has yet been reached. Lo and coeorkers8 reported that in-
flammation was associated with postoperative AF, and AF
occurs less frequently in cases in which the preoperative
CRP level is low. In recent years, reports that incidents of
postoperative AF are fewer in patients undergoing off-
pump CABG have been presented.9 It has been reported
that one cause is that CPB can induce inflammation.
TABLE 3. Intraoperative and postoperative data
AF (þ) AF () P value
ACCT (min) 28.7  14.0 27.3  13.2 .476
CPBT (min) 102.7  23.5 99.4  28.0 .373
Bypass 3.15  0.86 3.18  0.85 .761
Mortality 2 (2.7%) 0 .035
Complication 13 3 .023
Hospital stay (d) 25.3  22.4 15.8  7.90 <.001
ANP in RA (pg/wmg) 115.5  106.1 208.5  210.5 .007
I-CTP in RA (ng/wmg) 0.149  0.086 0.114  0.041 .0028
Hyaluronic acid
in RA (ng/wmg)
268.6  103.5 222.7  76.4 <.001
Peak CK–MB (U/L) 76.2  74.2 61.3  42.3 .11
Maximum troponin I
(ng/dL)
14.5  15.0 13.7  13.1 .722
Maximum angiotensin II
(pg/dL)
30.7  44.0 15.5  20.7 .0014
Maximum BNP (pg/dL) 509.9  405.3 496.6  514.9 .859
Maximum CRP (mg/dL) 4.56  2.92 4.71  2.90 .768
Maximum ANP (pg/dL) 182.8  352.8 157.6  215.3 .542
Minimum ANP (pg/dL) 44.7  26.3 68.2  46.6 <.001
AF, Atrial fibrillation; ACCT, aortic crossclamp time; CPBT, cardiopulmonary bypass
time; ANP, atrial natriuretic peptide; RA, right atrium; I-CTP, pyridinoline cross-linked
telopeptide of type I; CK–MB, creatine kinase– MB isoenzyme; BNP, brain natriuretic
peptide; CRP, C-reactive protein; wmg, weight of tissue/saline (2 mL).Cardiovascular Surgery c Volume 137, Number 4 897
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FIGURE 1. Correlation between the preoperative levels of atrial natriuretic peptide (ANP), pyridinoline cross-linked telopeptide of type I collagen (I-CTP),
and hyaluronic acid in the blood and ANP, I-CTP, and hyaluronic acid in the right atrium.However, there is a report of a randomized study that
reported that neither off-pump CABG nor conventional
CABG affected the occurrence of postoperative AF.10,11
Therefore such factors as the age of a patient rather than
factors associated with surgical intervention are believed
to have a stronger effect on the occurrence of AF. It is clear
in many reports that advanced age is closely associated with
the occurrence of AF, and to the extent of our exhaustive
research, no reports indicate that advanced age is not associ-
ated with the occurrence of AF. Amar and colleagues3
reported that AF tends to occur in cases in which the P-
wave duration is at least 100 ms in a preoperative electrocar-
diogram, whereas Zaman and associates2 reported that AF
tends to occur in cases in which the single averaged
P-wave duration is at least 155 ms, and this duration tends
to increase as patients increase in age. Nakai and associates12
reported that postoperative AF commonly occurs in cases of
advanced age and a history of AF, and a histologic study on
the right atrium examined during surgical intervention sug-
gests that the progression of fibrosis of the right atrium in-
creases as the patients increase in age, which is associated
with the occurrence of postoperative AF.
There is also a report that b-blockers and amiodarone are
effective in preventing postoperative AF.13 Conversely,
some reports suggest that the preoperative use of b-blockers
is not associated with AF.7,12 In this study there were few
cases in which a b-blocker was administered before surgical
intervention, and therefore we are unable to verify this point,
but statistically, it was not associated with the occurrence of
postoperative AF.
We studied the fibrosis of tissue caused by aging in seek-
ing an effective marker for the prevention of the occurrence
of postoperative AF before surgical intervention. We exam-898 The Journal of Thoracic and Cardiovascular Suined KL-6, hyaluronic acid, I-CTP, and ANP as fibrotic
markers in this study. KL-6 is a sialylated carbohydrate an-
tigen that is present on mucin-1 and is said to be a biomarker
with high specificity for pulmonary fibrosis.14 Hyaluronic
acid is said to be a mucous mucoperiosteum with a high mo-
lecular weight that is widely distributed throughout the con-
nective tissues in a living body, and it is metabolized in the
liver. It has also been shown to exhibit high values in cases
of hepatic fibrosis.15 Type I collagen is a protein that ac-
counts for 90% of bone matrix. Type I collagen in bone tis-
sues is degraded during bone absorption, thus causing I-CTP
to be released into the blood from the C-terminus, and is se-
lectively metabolized in the liver. It has been demonstrated
to exhibit high values in cases of I-CTP osteoporosis and
hepatic fibrosis.16
ANP is a hormone secreted in response to an extension of
the atrium, and when fibrosis of the atrium progresses, secre-
tion decreases.17,18 There are few studies on the relationship
between AF and I-CTP, hyaluronic acid, and KL-6, and we
did not find any report related to cardiac surgery. Boldt and
colleagues19 reported that levels of collagen type III and I are
significantly higher in patients with AF than in patients with
a normal sinus rhythm, whereas Tziakas and associates20 re-
ported that serum levels of the carboxyterminal propeptide
of collagen type I are significantly higher in patients with
AF than in patients with a normal sinus rhythm. Luo and
coworkers21 reported that type I collagen volume fraction
in the atria of patients with AF is significantly higher than
that seen in patients with a normal sinus rhythm, thus play-
ing a significant role in the fibrosis of the arterial muscle and
suggesting that carboxyterminal propeptide of collagen type
I might be a marker that could predict the occurrence of
postoperative AF.rgery c April 2009
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currence of AF at all preoperative levels of KL-6, hyaluronic
acid, I-CTP, and ANP in the blood. KL-6 levels were mea-
sured from the right atrium in this study; however, we were
unable to obtain a measured value, and therefore it is be-
lieved that there is little possibility of such secretion in the
atrium. However, it was measurable in the blood, and there-
fore this study suggests its effectiveness as a marker that
might predict postoperative AF.
In terms of ANP, no report related to CABG has yet been
published, but ANP is a hormone that is secreted from the
atrial wall in response to the extension of the atrium. As age
and fibrosis of the right atrium progress, ANP is believed to
be poorly secreted because of poor extension of the atrial
wall. ANP suppresses the renin–angiotensin–aldosterone
system (RAAS), and angiotensin II is said to stimulate
the development of fibroids. In a study on CABG, White
and coworkers22 presented a report in which the administra-
tion of ACE-I and ARB before surgical intervention re-
duces postoperative AF, whereas Guler and associates23
published a report in which angiotensin II levels were
shown to be significantly higher in cases in which AF
occurred when angiotensin II was measured on day 2 after
surgical intervention. Because angiotensin II causes electro-
physiologic and structural remodeling,24,25 ACE-I and
ARB have been reported to prevent the occurrence of post-
operative AF because it suppresses angiotensin II.22 For the
first time internationally, we therefore proposed a method
of continuously administering low doses of hANP (Daiichi
Pharmaceutical, Inc, Tokyo, Japan and Suntory, Inc, Osaka,
Japan) from the initiation of extracorporeal circulation dur-
ing cardiac surgery,26 and we have verified that postopera-
tive AF occurs less frequently in cases in which hANP is
administered while incorporating it into a prospective
randomized trial.27 In this study we believe that the sup-
pression of ischemic reperfusion disorder and the mainte-
nance of potassium levels resulted in the less frequent
occurrence of AF. However, according to the results of
this study, namely that the minimum value of the postoper-
ative ANP was significantly lower in cases in which AF oc-
curred than in cases in which AF did not occur, the
suppression of the decrease in ANP concentration during
the preoperative period through the administration of
hANP is therefore suggested to be associated with a lack
of occurrence of AF. Furthermore, the postoperative sup-
pression of angiotensin II with hANP is also believed to
be one of the causes of AF. The RAAS becomes more ac-
tive because of extracorporeal circulation. However, hANP
was observed to suppress the RAAS, as was also proved in
our previous studies. We thus believe that the AF of elec-
trophysiologic and structural remodeling occurs when an-
giotensin II levels increase, thus resulting in the
occurrence of AF. We would thus like to further study
the method of administering postoperative low doses ofThe Journal of Thoracic and ChANP during cardiac surgery while focusing on postopera-
tive AF in the future.
This study revealed that postoperative AF frequently oc-
curs in cases in which the patients are at least 70 years old,
the EuroSCORE is at least 8 points, and the postoperative
value of ANP is no more than 20 pg/dL, KL-6 is at least
30 U/mL, I-CTP is at least 10 ng/mL, and hyaluronic acid
is at least 80 ng/mL in the blood. This study suggests that
the preoperative blood concentrations of ANP, angiotensin
II, KL-6, hyaluronic acid, and I-CTP are effective as new in-
dices for predicting the occurrence of AF after CABG.
Therefore in such cases adjuvant therapies, such as those
in which the level of ANP in the blood is kept high through
the administration of a b-blocker or amiodarone before sur-
gical intervention or in which hANP is administered during
and after surgical intervention, might prevent postoperative
AF, and we would like to elucidate these points in future
studies.
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